Market Overview

UPDATE: Morgan Stanley Raises PT on Agilent on Multi-Year Margin Improvement Story

Share:
Related A
Pressure Biosciences CEO On Its Beaten Down Stock: 'We Can Now Begin To Focus On The Area That Is Most Important'
The Market In 5 Minutes: DryShips, Trump And Target
Cancer Immunotherapy Market: 2016 Takeaways And What To Expect In 2017 (Seeking Alpha)

In a report published Friday, Morgan Stanley analyst Daniel Brennan reiterated an Overweight rating on Agilent Technologies (NYSE: A), and raised the price target from $49.00 to $60.00.

In the report, Morgan Stanley noted, “We like Agilent's multi-year margin improvement story, organic growth profile and superior ROIC profile – all of which have been overshadowed by the macro weakness. The decision to break the company into two pieces is an important value-creating event, allowing the appropriate investor bases to analyze/evaluate each piece (leading to multiple expansion), enabling separate mgmt teams to form distinct strategies and allocate capital appropriately, and affording upside optionality given sector consolidation.”

Agilent Technologies closed on Thursday at $50.98.

Latest Ratings for A

DateFirmActionFromTo
Nov 2016Leerink SwannAssumesOutperform
Aug 2016Goldman SachsMaintainsBuy
Aug 2016Evercore ISI GroupMaintainsBuy

View More Analyst Ratings for A
View the Latest Analyst Ratings

Posted-In: Daniel Brennan Morgan StanleyAnalyst Color Price Target Analyst Ratings

 

Related Articles (A)

View Comments and Join the Discussion!